共 168 条
[1]
Hindricks G(2020)2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) Eur Heart J 42 373-498
[2]
Potpara T(2018)Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report Chest 154 1121-1201
[3]
Dagres N(2019)2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the heart rhythm society J Am Coll Cardiol 74 104-132
[4]
Arbelo E(2007)Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 857-867
[5]
Bax JJ(2003)Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation N Engl J Med 349 1019-1026
[6]
Blomstrom-Lundqvist C(2012)Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis Arch Intern Med 172 623-631
[7]
Lip GYH(2014)Optimal INR level in Thai atrial fibrillation patients who were receiving warfarin for stroke prevention in Thailand J Med Assoc Thai 97 1274-1280
[8]
Banerjee A(2020)Optimal INR level in elderly and non-elderly patients with atrial fibrillation receiving warfarin: a report from the COOL-AF nationwide registry in Thailand J Geriatr Cardiol 17 612-620
[9]
Boriani G(2020)Optimal INR level in patients with atrial fibrillation with EHRA type 2 valvular heart disease receiving warfarin J Arrhythm 36 425-429
[10]
Chiang CE(2020)Revisiting rate versus rhythm control in atrial fibrillation: timing matters N Engl J Med 383 1383-1384